Signaling via Notch receptors is essential for the generation of early progenitors of the T cell lineage (ETPs) in the thymus 1, 2 . Notch signaling both upregulates T cell lineage-specific gene expression and antagonizes alternative fates as progenitor cells commit to the T cell lineage [3] [4] [5] [6] [7] [8] [9] . ETPs retain the potential to develop into non-T cell lymphoid cells (B cells and natural killer cells), dendritic cells and, to a degree, myeloid cells 1, 7, [10] [11] [12] [13] [14] [15] , in addition to robust potential to develop into T cells; however, the intrathymic mechanisms that repress non-T cell lineage-specific programs are not well understood. Consequently, the importance of the repression of alternative fates for T cell development has not been clearly demonstrated.
Hes1 is a basic helix-loop-helix transcriptional repressor 16 and an evolutionarily conserved target of Notch signaling 17, 18 . Germline deletion of Hes1 results in the absence of the thymus (in >90% of such mice) or a severely hypocellular thymus, in addition to defects in the pancreas, gut, bile duct and neural tube that are lethal late in embryogenesis 16, 19, 20 . The absence of a thymus in Hes1-deficient embryos may reflect defects in both hematopoietic cells and thymic stromal cells, because Hes1 is expressed in both cell types 19 . Hematopoietic cell-intrinsic expression of Hes1 is important for T cell development, and Hes1-deficient progenitor cells fail to generate normal numbers of T cells in competitive fetal liver (FL) or bone marrow (BM) chimeras or after direct intrathymic injection; however, the defect is not absolute 19, 21 . It has been suggested that Hes1 facilitates the population expansion of T cell progenitors, possibly via repression of Cdkn1b (which encodes the cell-cycle inhibitor p27 Kip1 ) 22, 23 .
Several studies have suggested an antagonistic relationship between Hes1 and C/EBP-α, a critical regulator of the development of myeloid cells and dendritic cells 24, 25 , as well as adipogenesis 26 . Ectopic expression of Hes1 inhibits myelopoiesis from BM progenitor cells 5, 27 . Furthermore, during the development of mast cells, Notch2 signaling upregulates the expression of Gata3, which encodes the transcription factor and T cell regulator GATA-3, and Hes1, which encodes Hes1, thought to repress the gene encoding C/EBP-α (Cebpa) and prevent diversion of the progenitors of mast cells to other myeloid fates 28, 29 . Because progenitor cells of T cells have high expression of Hes1, we considered that Hes1 may constrain C/EBP-α and perhaps other myeloid factors early in T cell development 19 .
The attenuation of myeloid potential in hematopoietic progenitor cells begins prethymically in FL and BM and results in the generation of IL-7Rα + lymphoid progenitor cells 30, 31 . However, Hes1 is dispensable for the development of B cells and type 2 innate lymphoid cells, which suggests it is not essential for extrathymic lymphoid specification 15, 19, 21, 32 . As progenitor cells enter the thymus and experience strong Notch signaling, myeloid gene-expression programs may need to be actively repressed to allow specification to the T cell lineage to proceed. Ectopic C/EBP-α expression in CD4 − CD8 − double-negative (DN) thymocytes experiencing Notch signaling inhibits survival and subsequent T cell development 33 . Consistent with that, ETPs with higher C/EBP-α expression (as identified in a reporter mouse strain) are less efficient progenitors of T cells than are those with lower C/EBP-α expression 34 . Here we report that deletion of C/EBP-α eliminated the requirement for Hes1 during T cell development. Thus, constraint of 1 2 7 8 VOLUME 14 NUMBER 12 DECEMBER 2013 nature immunology A r t i c l e s conflicting myeloid gene expression programs via Hes1 is a critical prerequisite for the specification and commitment of T cells.
RESULTS

Hes1 is essential for T cell lymphopoiesis
We examined Hes1 expression in BM and thymic progenitor cells of wild-type adult mice by quantitative PCR. ETPs and thymocytes at double-negative stage 2 (DN2) and DN3 from adult mice had high expression of the Notch1 targets Hes1 and Dtx1 (which encodes the transcriptional regulator deltex-1), whereas those transcripts were low or absent in BM Lin − Sca-1 + c-Kit + (LSK) cells and lymphoid-primed multipotential progenitor cells (Fig. 1a) . We did not detect expression of Hes1 or Dtx1 mRNA in CD4 + CD8 + double-positive thymocytes, consistent with the termination of Notch signaling after the β-selection checkpoint 35 . Common lymphoid progenitor cells 30 lacked Dtx1 expression but had low expression of Hes1 mRNA, perhaps because transcription factors such as E47 can induce Hes1 independently of Notch 36 . Expression of Cebpa followed a pattern that was reciprocal to that of Hes1. BM LSK and lymphoid-primed multipotential progenitor populations had high expression of Cebpa mRNA, which was downregulated in common lymphoid progenitor cells, consistent with the attenuated myeloid potential of those cells 30 . Cebpa expression was further reduced in ETPs and was almost completely extinguished in DN2 and DN3 thymocytes, in agreement with exposure to strong intrathymic Notch1 signaling and correlating with upregulation of Hes1 expression. These data suggested that Hes1 may repress Cebpa in progenitor cells that have settled the thymus and are exposed to Notch1 ligands.
Hes1 and Dtx1 were expressed in fetal DN2 thymocytes but had low or absent expression in FL progenitor cells and Mac-1 + myeloid cells (Fig. 1b) . We detected low expression of Hes1 mRNA in FL lymphoid progenitor cells (Lin − c-Kit + Flt3 + IL-7Rα + ), analogous to BM common lymphoid progenitor cells. Cebpa expression was high in FL Lin − c-Kit + Flt3 − and Flt3 + IL-7Rα − multipotent progenitors (MPPs) and was downregulated in Flt3 + IL-7Rα + lymphoid progenitor cells. Cebpa expression was further diminished in fetal thymocytes, indicative of a reciprocal relationship between Hes1 expression and Cebpa expression.
The thymus was either absent or extremely hypocellular in Hes1-deficient (Hes1 −/− ) embryos 19 (Supplementary Fig. 1a) , which precluded detailed analysis of fetal thymocyte populations. Germline deletion of Hes1 is lethal perinatally, but we were able to assess FL progenitor cells and found similar frequencies of Lin − c-Kit + Flt3 + IL-7Rα + lymphoid progenitor cells in Hes1 −/− FL and wild-type FL at embryonic days 12.5-13.5 (E12.5-E13.5) 37 (Fig. 1c) . We also assessed Cebpa expression in FL cells and found it was downregulated in FL Lin − c-Kit + Flt3 + IL-7Rα + lymphoid progenitor cells from Hes1 −/− mice relative to its expression in FL Lin − c-Kit + Flt3 + IL-7Rα − MPPs from Hes1 −/− mice, to a degree similar to that of control progenitor cells from their Hes1 +/+ littermates (Fig. 1d) . These results indicated that Hes1 was not necessary for downregulation of Cebpa expression in FL lymphoid progenitor cells before exposure to intrathymic Notch signals. Other transcription factors such as E2A that mediate lymphoid specification may fulfill this role 36 .
To determine the stage of T cell development that requires Hes1, we generated competitive chimeras by mixing whole FL from Hes1 −/− mice or their Hes1 +/+ littermates with BM from adult hosttype mice (at a ratio of 1:2, FL to BM) and intravenously injecting the mixture into lethally irradiated host mice. We examined the reconstitution of hematopoietic lineages in the recipient mice after 15, 21 (DN2 chimerism of Hes1 −/− cells was <2% that of BM chimerism; Supplementary Fig. 1b) . Cebpa expression was sharply downregulated by the DN2 stage of T cell development (Fig. 1a) , which suggested that Hes1 may inhibit Cebpa expression during the ETP-to-DN2 transition. Furthermore, Hes1 −/− Lin − c-Kit + Flt3 + progenitor cells were defective in generating CD4 + CD8 + double-positive T cells when mixed with host-type Hes1 +/+ BM LSK competitor cells and directly injected into the thymus of sublethally irradiated congenic host mice ( Supplementary  Fig. 1c) , as expected 21 .
Notch constrains myeloid potential through Hes1
To better investigate the requirement for Hes1 during T cell development, we cultured Hes1 −/− FL progenitor cells with OP9 stromal cells or OP9 cells that express the Notch ligand Delta-like 4 (OP9-DL4) and stimulated the cocultures with the cytokines IL-7 (interleukin 7) and Flt3L (the ligand for the receptor tyrosine kinase Flt3). Given that MPP have robust myeloid potential, whereas lymphoid progenitor cells have attenuated that potential 30, 31 , we investigated the differentiation potential of sorted FL Lin − c-Kit + Flt3 + IL-7Rα − MPPs and Lin − c-Kit + Flt3 + IL-7Rα + lymphoid progenitor cells from Hes1 −/− embryos and their Hes1 +/+ littermates. Hes1 +/+ Lin − c-Kit + Flt3 + IL-7Rα − MPPs generated mostly myeloid cells and few B cells in OP9 cultures, whereas Lin − c-Kit + Flt3 + IL-7Rα + lymphoid progenitor cells generated predominantly B cells and few myeloid cells ( Fig. 2a and Supplementary Fig. 2a ). Hes1 −/− FL MPPs and lymphoid progenitor cells had developmental potential similar to that of their Hes1 +/+ counterparts in the absence of Notch signaling ( Fig. 2a and Supplementary Fig. 2a ). On OP9-DL4 cells, which activate Notch signaling, the number of Thy-1 + CD25 + progeny of the T cell lineage generated from either Hes1 −/− MPPs or Hes1 −/− lymphoid progenitor cells was much lower than that generated by Hes1 +/+ progenitor cells ( Fig. 2b and Supplementary Fig. 2b ). Notch signaling effectively inhibited myeloid development from Hes1 +/+ MPPs 6 , while Hes1 −/− MPP generated large numbers of Mac-1 + progeny, many of which coexpressed the monocyte marker Gr-1 ( Fig. 2b and Supplementary  Fig. 2c ). In contrast to Hes1 −/− MPPs, Hes1 −/− lymphoid progenitor cells generated very few Mac-1 + cells, which were largely Gr-1 − ( Fig. 2b and Supplementary Fig. 2c ). Notch-mediated inhibition of B cells remained intact in Hes1 −/− MPPs and lymphoid progenitor cells (Fig. 2c) . Mac-1 − Thy-1 − undifferentiated cells in OP9-DL4 cultures initiated with Hes1 −/− FL lymphoid progenitor cells showed more annexin V staining than did cultures initiated with Hes1 +/+ control lymphoid progenitor cells, and they decreased in number by day 4 in the former cultures (Fig. 3a) . After supplementation of OP9-DL4 cultures with myeloid cytokines (SCF, Flt3L, IL-3, M-CSF, GM-CSF and G-CSF), Hes1 −/− FL lymphoid progenitor cells generated more Mac-1 + cells than did Hes1 +/+ FL lymphoid progenitor cells (Fig. 3b) . Mac-1 + cells generated from either Hes1 +/+ or Hes1 −/− lymphoid progenitor cells were mainly CD11c + (Fig. 3b) . These results indicated that Hes1 was required for Notch1-mediated inhibition of the development of myeloid cells, but not B cells, from MPPs. However, in contrast to Hes1 −/− MPPs, Hes1 −/− lymphoid progenitor cells did not readily divert to myeloid fates in T cell-inductive conditions unless myeloid cytokines were provided.
We further separated FL lymphoid progenitor cells on the basis of their expression of PIR, which marks prethymic T cell lineagecommitted progenitor cells and recent thymic immigrants 37 . PIR − and PIR + progenitor cells were present at a similar frequency in Hes1 −/− and Hes1 +/+ mice 37 (Supplementary Fig. 3a ). Both PIR − and PIR + Lin − c-Kit + Flt3 + IL-7Rα + progenitor cells from Hes1 −/− mice failed to generate normal numbers of CD25 + T cells and did not divert to myeloid fates in OP9-DL4 cultures with the cytokines IL-7 and Flt3L 37 ( Supplementary Fig. 3b ).
To investigate whether myeloid gene expression was affected by the absence of Hes1, we cultured Hes1 −/− Lin − c-Kit + Flt3 + total FL progenitor cells on OP9-DL4 stromal cells and isolated Mac-1 − CD25 − cells by cell sorting after 6 d, followed by gene-expression analysis. The expression of the myeloid-lineage genes Cebpa and Csf1r was higher in cultures initiated with Hes1 −/− progenitor cells than in cultures initiated with Hes1 +/+ control progenitor cells ( Supplementary Fig. 4 ). Those data were consistent with expanded myeloid output from the Hes1 −/− population; however, expression of Sfpi1 (which encodes the transcription factor PU.1) was similar in cultures initiated with Hes1 −/− progenitor cells and those initiated with Hes1 +/+ control progenitor cells. We also examined expression of Cdkn1b, which encodes the cyclin-dependent kinase inhibitor p27 Kip and is suggested to be a Hes1 target 22, 23 ; however, Cdkn1b expression was not upregulated in Mac1 − CD25 − cells from OP9-DL4 cultures initiated with Hes1 −/− FL progenitor cells relative to its expression in those initiated with Hes1 +/+ FL progenitor cells (Supplementary Fig. 4) . We also analyzed gene expression in (Fig. 3c) , consistent with the expanded myeloid output from Hes1 −/− MPPs (Fig. 2b) . In similar conditions, we did not observe a difference between cells derived from Hes1 −/− IL-7Rα + Lin − c-Kit + Flt3 + cells and those derived from their Hes1 +/+ counterparts in their Cebpa expression. These results suggested that MPPs and lymphoid progenitor cells responded differently to T cell-inductive Notch signaling in the absence of Hes1: Hes1 −/− MPPs exposed to Notch signaling diverted to myeloid fates, whereas Hes1 −/− lymphoid progenitor cells exposed to Notch ligands were unable to efficiently adopt either the T cell fate or the myeloid cell fate and exhibited increased apoptosis.
Hes1 represses Cebpa
We studied how ectopic expression of Hes1 in hematopoietic progenitor cells resulted in downregulation of Cebpa. We treated C57BL/6 mice with the chemotherapeutic agent 5-fluorouracil for enrichment for hematopoietic stem cells, collected BM from those mice, retrovirally transduced the BM with vector encoding human Hes1 or empty vector and injected the BM intravenously into irradiated host mice. In this system, expression of green fluorescent protein (GFP) is used to track transduced cells. We used cell sorting to isolate GFP + BM LSK progenitor cells from mice reconstituted with the transduced BM and analyzed gene expression by quantitative PCR. Ectopic expression of Hes1 resulted in downregulation of Cebpa in BM LSK progenitor cells 5, 27, 28 (Fig. 4a) . To determine whether Hes1 affects the expression of C/EBP-α protein, we retrovirally transduced the 32D mouse myeloid cell line with Hes1-encoding vector or empty vector and isolated transduced cells after 48 h by cell sorting according to GFP expression. Immunoblot analysis indicated that cells transduced with the Hes1-encoding vector had less C/EBP-α than did those transduced with empty vector (Fig. 4b) . Hes1 inhibits gene expression by direct DNA binding and by recruitment of Groucho corepressors through its carboxy-terminal Trp-Arg-Pro-Trp (WRPW) domain 16 . However, Hes1 can also inhibit gene expression by interacting with positively acting basic helix-loophelix transcription factors and decreasing their affinity for activating E-box sites 16 (Fig. 4c) . Hes1 overexpression did not affect the expression of Sfpi1 or Cdkn1b (Fig. 4c) , consistent with our loss-of-function data ( Supplementary Fig. 4 ) and published data 40 . We also assessed the ability of the mutant Hes1 constructs to support the development of T cells and inhibit the development of myeloid cells. Expression of wild-type Hes1 in Hes1 −/− progenitor cells restored T cell development and suppressed myelopoiesis in OP9-DL4 cultures, but expression of either Hes1 mutant did not (Fig. 3d,e) . Transduction of retrovirus encoding the mutant Hes1 lacking the DNA-binding domain neither restored T cell development nor inhibited myelopoiesis in OP9-DL4 cultures (Fig. 4d) . Transduction of retrovirus encoding the mutant Hes1 lacking the WRPW domain led to some T cell development in OP9-DL4 cultures; however, this was much lower than that resulting from transduction of retrovirus encoding wild-type Hes1 (Fig. 4e) . These results suggested that DNA binding and interaction with Groucho proteins were important for Hes1-mediated inhibition of Cebpa expression and Hes1 function. Analysis of the mouse Cebpa promoter revealed several putative Hes1-binding (N-box) sites (Fig. 4f) , which suggested a role for Hes1 in directly regulating this gene. A Hes1-binding site 165 base pairs upstream of the Cebpa transcriptional start site is bound by Hes1 in 32D cells 27 . Chromatin immunoprecipitation (ChIP) analysis showed enrichment for Hes1 binding at the site 165 base pairs upstream but not at another site 1.2 kilobases upstream of the transcriptional start site in DN3 thymocytes (Fig. 4f) . Hes1 also bound its own promoter in DN3 thymocytes, consistent with Hes1 autoregulation 41 , but did not bind a negative control site (Fig. 4f) . Moreover, Hes1 repressed the activity of a luciferase reporter containing Cebpa promoter sequence (Fig. 4g) . Mutation of the Hes1-binding site in the reporter abolished that effect (Fig. 4g) . These data suggested that Hes1 may directly bind the Cebpa promoter and repress its transcription in progenitors of T cells through interaction with Groucho corepressors.
Deletion of C/EBP-a restores T cell lymphopoiesis without Hes1
To determine whether the main role of Hes1 in T cell development is to repress Cebpa expression or related myeloid gene-expression programs, we investigated whether deletion of C/EBP-α would restore the development of T cells from Hes1-deficient progenitor cells. We generated Hes1 +/− mice with loxP-flanked Cebpa alleles (Cebpa fl/fl ) 42 and then intercrossed those mice to obtain Hes1 −/− Cebpa fl/fl embryos. To delete C/EBP-α, we transduced FL Lin − c-Kit + Flt3 + MPPs from 24, 42 (Fig. 5a) . Both Cre-GFP + and Cre-GFP − Hes1 +/− Cebpa fl/fl progenitor cells robustly produced T cell populations on OP9-DL4 cells, because C/EBP-α is not required for T cell development 24 . In similar cultures, only Cre-GFP + Hes1 −/− Cebpa fl/fl progenitor cells gave rise to robust populations of CD25 + T lineage cells, while Cre-GFP − Hes1 −/− Cebpa fl/fl cells generated mostly Mac-1 + myeloid cells and very few T cells. These data indicated that deletion of C/EBP-α restored the T cell potential of Hes1 −/− progenitor cells. Furthermore, they established that the effects of C/EBP-α deletion were cell autonomous.
To quantify the effect of the deletion of C/EBP-α in Hes1 −/− progenitor cells, we transduced Hes1 −/− Cebpa fl/fl Lin − c-Kit + Flt3 + FL progenitor cells with Cre-GFP or with retroviral vector encoding GFP alone (empty vector), cultured them on OP9-DL4 stromal cells and examined the cultures by flow cytometry after 7 d. Significantly more CD25 + T cells were generated by Hes1 −/− Cebpa fl/fl progenitor cells transduced with Cre-GFP than by those transduced with empty vector (Fig. 5b) . We also assessed Cre-GFP + progenitor cells in OP9-DL4 cultures by limiting-dilution analysis. Although the frequency of T cell progenitors among transduced cells was lower than that among untransduced cells (data not shown), the frequency of T cell progenitors was similar among Cre-GFP + Hes1 −/− Cebpa fl/fl cells (1/43) and Cre-GFP + Hes1 +/+ Cebpa fl/fl cells (1/56), and both of those frequencies were significantly higher than that of Hes1 −/− Cebpa fl/fl cells transduced with empty vector (1/170) (Fig. 5c) . Thus, deletion of C/EBP-α substantially improved the A r t i c l e s hematopoietic cells 43 . (Fig. 6a-d and Supplementary Fig. 5 ). As an additional control, we did not detect Hes1 mRNA in DN3 thymocytes derived from Hes1 −/− Cebpa fl/fl Vav1-Cre cells (Fig. 6b) . The controls used in these experiments were either Hes1 +/− Cebpa fl/fl Vav1-Cre cells or Hes1 +/− Cebpa fl/+ Vav1-Cre cells (Fig. 6d) (Fig. 6e) . These results suggested that failure to downregulate myeloid lineage gene expression prohibited T cell development, even in the absence of overt diversion to the myeloid lineage (Supplementary Fig. 6 ). These findings demonstrated that deletion of the myeloid factor C/EBP-α eliminated the requirement for Hes1 in T cell development in vivo.
DISCUSSION
To investigate the mechanism and importance of alternative-lineage gene repression during early T cell development, we focused on the canonical Notch target and basic helix-loop-helix transcriptional repressor Hes1. Hes1-deficient progenitor cells have a profound, but incomplete, developmental defect in the T cell lineage attributed to inadequate population expansion of early progenitor cells 19, 21 ; however, the precise cause of the defect has remained unknown. Because Hes1 robustly inhibits Cebpa expression and myeloid potential 5,27,28 , we investigated whether Hes1 constrains myeloid-lineage gene-expression programs in early T cell development. We found that deletion of C/EBP-α in Hes1-deficient progenitor cells restored in vivo T cell development to wild-type amounts. Hence, our results establish that the main, and perhaps only, role of Hes1 in T cell development is to inhibit myeloid gene-expression programs.
Our results suggest that C/EBP-α expression must be downregulated for specification to the T cell lineage to proceed, consistent with the observed decrease in Cebpa mRNA as thymocytes progressed from ETP to DN2. Notably, the consequences of Hes1 deficiency differed in MPP and lymphoid progenitor populations. Hes1-deficient MPPs displayed a developmental bias toward myeloid cells and dendritic cells after Notch signaling, even in the absence of exogenous myeloid cytokines, whereas Hes1-deficient lymphoid progenitor cells underwent apoptosis in the same conditions. Additionally, our results indicated that the threshold for the myeloid diversion of lymphoid progenitor cells was higher than that for the diversion of MPPs after Notch signaling in vitro, because in our studies, the former required the provision of myeloid cytokines. Our results are consistent with published work showing that ectopic expression of myeloid transcription factors in DN thymocytes conferred a survival disadvantage in T cell-inductive conditions 33, 44 . These data may also explain why diversion of Hes1-deficient progenitors of T cells to myeloid fates is not apparent in the thymus of FL chimeras 15, 21 . Notably, deletion of C/EBP-α restored the development of both Hes1-deficient MPPs and Hes1-deficient lymphoid progenitor cells into T cells, which indicated that failure to constrain myeloid-lineage gene expression inhibits T cell development even in the absence of overt diversion into the myeloid lineage.
Our work and that of others 27 suggests that Hes1 directly represses Cebpa, because the Hes1 DNA-binding domain is necessary for inhibition of C/EBP-α and Hes1 binds to the Cebpa promoter in DN3 thymocytes. Furthermore, Hes1 may rely on Groucho corepressors for its function 45 , as alteration of the carboxy-terminal WRPW Grouchointeraction domain greatly decreased Hes1 function. Although our data suggest that Hes1 might repress Cebpa directly in progenitors of T cells, Hes1 may also act on other effector molecules in the same pathway.
Hes1-deficient cells are resistant to the induction of T cell acute lymphoblastic leukemia through the introduction of intracellular Notch, and continuous Hes1 signaling is required to maintain Notch-induced T cell acute lymphoblastic leukemia 21 . Moreover, Hes1 may contribute to human myeloid malignancies via suppression of C/EBP-α 46 . At this time, it is unknown whether similar mechanisms downstream of Hes1 operate during the processes of T cell development and the induction or maintenance of T cell acute lymphoblastic leukemia.
Our observations help explain the sequential loss of non-T cell potential during early T cell development. We propose that the main function of Hes1 during T cell development is to constrain myeloid gene-expression programs. Hes1 was not required for the inhibition of B cell fate, a process that is probably mediated by other Notch effector molecules (such as TCF-1 and GATA-3) 8, 9 . The transcriptional regulator Bcl-11b may constrain myeloid potential after the ETP stage, as it is expressed in DN2 thymocytes and inhibits Cebpa expression 47, 48 . Consistent with the idea that biochemically and temporally distinct mechanisms act together to inhibit non-T cell lineage programs, analysis of sequential T cell progenitor populations by ChIP and deep sequencing has revealed that diverse histone modifications mark different genes that encode hematopoietic regulatory molecules across development 49 . In FL-derived DN1 cells cultured with Notch ligands 49 and in wild-type ETP, DN2 and DN3 thymocytes (our unpublished data), the Cebpa transcriptional start site was bivalently marked with the activating histone marks H3K4me3 or H3K(9,14)Ac, as well as the repressive mark H3K27me3, which suggests that repression had initiated in at least some cells. Hes1 is no longer expressed after the DN3 stage 35 , which indicates that additional mechanisms are probably needed to silence myeloid genes in committed progenitors of T cells and mature T cells. Because progenitor cells lacking Cebpa and Hes1 generated normal numbers of T cells, such mutant cells may be a useful tool with which to delineate stage-specific mechanisms by which regulators of the myeloid lineage are initially constrained and finally silenced during T cell development.
Our data support a model in which Notch signaling upregulates expression of the transcriptional repressor Hes1 shortly after entry into the thymus, coincident with the generation of ETPs. Hes1 directly inhibits expression of Cebpa, which encodes a critical myeloid regulator, and perhaps other myeloid-lineage genes, which remain accessible in early thymus-settling progenitor cells 15 . Thus, our findings establish the importance of constraining developmental programs of the myeloid lineage early in intrathymic T cell development, a task accomplished by inclusion of Hes1 in the gene-regulatory network that establishes T cell identity.
METHODS
Methods and any associated references are available in the online version of the paper. 
